Macrogenics
MGNX· Manufacturing· Fiscal year ends in December
CEO pay in FY2025Stock -50.5% in FY2025
Eric Risser is the CEO of Macrogenics and was paid $2.1M in FY2025 (Dec).
Pay$100 in the stock at the end of FY24 → $50
Executives4
See all- 1Eric RisserPresident, Chief Executive Officer and DirectorFY2025
- 2Ezio BonviniSenior Vice President, Research and Chief Scientific OfficerFY2025
- 3James KarrelsSenior Vice President and Chief Financial OfficerFY2025
- 4Scott Koenig, M.D., Ph.D.Former Chief Executive Officer and current DirectorFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allMacrogenics paid its 4 named executives $5.4M in total in FY2025 (Dec). CEO Eric Risser was paid $2.1M of that.
| Name | ||
|---|---|---|
| Eric RisserPresident, Chief Executive Officer and Director | Not disclosed | |
| Ezio BonviniSenior Vice President, Research and Chief Scientific Officer | Not disclosed | |
| James KarrelsSenior Vice President and Chief Financial Officer | ||
| Scott Koenig, M.D., Ph.D.Former Chief Executive Officer and current Director |
of each named executive, from the Summary Compensation Table of each proxy.
Peers19
See allThe comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.
Activity
No new filings about this company in the feed.
Filings6
See all| Proxy statement | DEF 14A | Apr 8, 2026 | FY2025 |
| Annual report | 10-K | Mar 9, 2026 | FY2025 |
| Proxy statement | DEF 14A | Apr 11, 2025 | FY2024 |
| Annual report | 10-K | Mar 20, 2025 | FY2024 |
| Proxy statement | DEF 14A | Apr 8, 2024 | FY2023 |
| Annual report | 10-K | Mar 7, 2024 | FY2023 |